Head-to-head · Cost-Efficiency Index
Get Thin MD vs GOAL.MD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Get Thin MD
Shoppers willing to commit to 12 months to lock in the lowest published compounded GLP-1 rate.
Visit Get Thin MDGOAL.MD
Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate.
Visit GOAL.MDThe verdict
Get Thin MD takes it, leading the Cost-Efficiency Index 72 to 71. Get Thin MD (GetThinUSA) is a nationwide-advertised telehealth platform selling compounded semaglutide and tirzepatide (plus brand Ozempic/Zepbound) alongside a broader wellness menu. GOAL.MD still earns a C — Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Get Thin MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Get Thin MD | GOAL.MD |
|---|---|---|
| Cost-Efficiency Index | 72/100 | 71/100 |
| Semaglutide / mo | $119/mo (starting dose, compounded) | $199/mo (promotional rate, compounded) |
| Tirzepatide / mo | $179/mo (starting dose, compounded) | $299/mo (compounded) |
| Semaglutide / yr (modeled) | $1,428 | $2,388 |
| Tirzepatide / yr (modeled) | $2,148 | $3,588 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Yes |
| Rank here | #75 | #81 |
Get Thin MD
72/100Where the value is
- Flat 'Lifetime Price Protection' pricing — the rate doesn't rise as your prescribed dose increases
- Both compounded and brand-name pathways (Ozempic, Zepbound) offered on one platform
- Bundles unlimited provider visits, labs, and shipping into the quoted price with 'No Membership or Hidden Fees EVER'
The tradeoffs
- The advertised $119/$179 headline requires a 12-month commitment; the true no-strings monthly price is $199/$299 — 67% higher
- No single named compounding pharmacy — which of the four named pharmacies fills your order isn't disclosed upfront
GOAL.MD
71/100Where the value is
- Named Chief Physician (Dr. Michael Mimlitz, MD) rather than an anonymous provider network
- Multiple product tiers (standard, micro-dose, combination 'Synergy') for different budgets and needs
- 3-month bundle discount available on the combination product ($547/mo vs. $597/mo single-month)
The tradeoffs
- The widely advertised '$149' price is a first-month-only discount; the standing rate is $199/mo semaglutide and $299/mo tirzepatide — more than double the headline for tirzepatide
- No named compounding pharmacy — only generic '503A & 503B licensed U.S. pharmacies' language
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.